These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 34835116)

  • 41. Dynamics of SARS-CoV-2 variants of concern (VOC) in Bangladesh during the first half of 2021.
    Afrin SZ; Islam MT; Paul SK; Kobayashi N; Parvin R
    Virology; 2022 Jan; 565():29-37. PubMed ID: 34700068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.
    Wang L; Cheng G
    J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phylogenomics and population genomics of SARS-CoV-2 in Mexico during the pre-vaccination stage reveals variants of interest B.1.1.28.4 and B.1.1.222 or B.1.1.519 and the nucleocapsid mutation S194L associated with symptoms.
    Barona-Gómez F; Delaye L; Díaz-Valenzuela E; Plisson F; Cruz-Pérez A; Díaz-Sánchez M; García-Sepúlveda CA; Sanchez-Flores A; Pérez-Abreu R; Valencia-Valdespino FJ; Vega-Magaña N; Muñoz-Valle JF; García-González OP; Bernal-Silva S; Comas-García A; Cibrián-Jaramillo A
    Microb Genom; 2021 Nov; 7(11):. PubMed ID: 34846283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 (beta) variant (20H/501Y.V2) in Brazil.
    Slavov SN; Patané JSL; Bezerra RDS; Giovanetti M; Fonseca V; Martins AJ; Viala VL; Rodrigues ES; Santos EV; Barros CRS; Marqueze EC; Santos B; Aburjaile F; Neto RM; Moretti DB; Haddad R; Calado RT; Kitajima JP; Freitas E; Schlesinger D; Junior de Alcantara LC; Elias MC; Sampaio SC; Kashima S; Covas DT
    J Med Virol; 2021 Dec; 93(12):6782-6787. PubMed ID: 34241897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monitoring the SARS-CoV-2 pandemic: screening algorithm with single nucleotide polymorphism detection for the rapid identification of established and emerging variants.
    Mertens J; Coppens J; Loens K; Le Mercier M; Xavier BB; Lammens C; Vandamme S; Jansens H; Goossens H; Matheeussen V
    Clin Microbiol Infect; 2022 Jan; 28(1):124-129. PubMed ID: 34537361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comprehensive overview of identified mutations in SARS CoV-2 spike glycoprotein among Iranian patients.
    Eslami S; Glassy MC; Ghafouri-Fard S
    Gene; 2022 Mar; 813():146113. PubMed ID: 34896524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada.
    Fibke CD; Joffres Y; Tyson JR; Colijn C; Janjua NZ; Fjell C; Prystajecky N; Jassem A; Sbihi H
    Front Public Health; 2022; 10():915363. PubMed ID: 35859775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of the SARS-CoV-2 Delta variant C22995A using a high-resolution melting curve RT-FRET-PCR.
    Barua S; Bai J; Kelly PJ; Hanzlicek G; Noll L; Johnson C; Yin JH; Wang C
    Emerg Microbes Infect; 2022 Dec; 11(1):14-17. PubMed ID: 34783635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Novel Strategy for the Detection of SARS-CoV-2 Variants Based on Multiplex PCR-Mass Spectrometry Minisequencing Technology.
    Zhao F; Lu J; Lu B; Qin T; Wang X; Hou X; Meng F; Xu X; Li T; Zhou H; Zhang J; Kan B; Huang Y; Zhang Z; Xiao D
    Microbiol Spectr; 2021 Dec; 9(3):e0126721. PubMed ID: 34787499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.
    Saha O; Islam I; Shatadru RN; Rakhi NN; Hossain MS; Rahaman MM
    Virus Genes; 2021 Oct; 57(5):413-425. PubMed ID: 34251592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SARS-CoV-2 Delta variant isolates from vaccinated individuals.
    Brinkac L; Diepold S; Mitchell S; Sarnese S; Kolakowski LF; Nelson WM; Jennings K
    BMC Genomics; 2022 Jun; 23(1):417. PubMed ID: 35658876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
    Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
    J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals.
    Huai Luo C; Paul Morris C; Sachithanandham J; Amadi A; Gaston DC; Li M; Swanson NJ; Schwartz M; Klein EY; Pekosz A; Mostafa HH
    Clin Infect Dis; 2022 Aug; 75(1):e715-e725. PubMed ID: 34922338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The biological and clinical significance of emerging SARS-CoV-2 variants.
    Tao K; Tzou PL; Nouhin J; Gupta RK; de Oliveira T; Kosakovsky Pond SL; Fera D; Shafer RW
    Nat Rev Genet; 2021 Dec; 22(12):757-773. PubMed ID: 34535792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discriminatory Weight of SNPs in Spike SARS-CoV-2 Variants: A Technically Rapid, Unambiguous, and Bioinformatically Validated Laboratory Approach.
    Musso N; Bonacci PG; Bongiorno D; Stracquadanio S; Bivona DA; Palermo CI; Scalia G; Fichera M; Stefani S
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan.
    Ko K; Takahashi K; Nagashima S; E B; Ouoba S; Hussain MRA; Akita T; Sugiyama A; Sakaguchi T; Tahara H; Ohge H; Ohdan H; Kubo T; Ishikawa N; Takafuta T; Fujii Y; Mimori M; Okada F; Kishita E; Ariyoshi K; Kuwabara M; Tanaka J
    Sci Rep; 2022 Feb; 12(1):2419. PubMed ID: 35165301
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape.
    Tian D; Sun Y; Zhou J; Ye Q
    Front Immunol; 2021; 12():751778. PubMed ID: 34917076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Viral loads and profile of the patients infected with SARS-CoV-2 Delta, Alpha, or R.1 variants in Tokyo.
    Tani-Sassa C; Iwasaki Y; Ichimura N; Nagano K; Takatsuki Y; Yuasa S; Takahashi Y; Nakajima J; Sonobe K; Nukui Y; Takeuchi H; Tanimoto K; Tanaka Y; Kimura A; Tohda S
    J Med Virol; 2022 Apr; 94(4):1707-1710. PubMed ID: 34825717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid Protein to Validate the Viral Quality Assurance Panels.
    Ray P; Ledgerwood-Lee M; Brickner H; Clark AE; Garretson A; Graham R; Van Zant W; Carlin AF; Aronoff-Spencer ES
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies.
    Kannan SR; Spratt AN; Sharma K; Chand HS; Byrareddy SN; Singh K
    J Autoimmun; 2022 Jan; 126():102779. PubMed ID: 34915422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.